Literature DB >> 18985466

Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis.

Mamede De Carvalho1, Michael Swash.   

Abstract

We have tested the sensitivity of a recently published approach to combining clinical and EMG data in the 'research diagnosis' of ALS, in 55 consecutive patients clinically diagnosed with ALS. The application of this 'Awaji algorithm' to the revised El Escorial diagnostic criteria for diagnosis of ALS achieved a diagnostic sensitivity of 95% for definite ALS compared with 18% using the clinical El Escorial criteria and 53% when the EMG criteria as defined in the El Escorial criteria, were applied to the same dataset. This increased sensitivity was particularly relevant for bulbar onset patients (sensitivity improved from 38% to 87%) and for patients with El Escorial clinically possible ALS (from 50% to 86%). We suggest that, in future, investigators and triallists should use the Awaji algorithm superimposed onto the El Escorial criteria, in selecting patients for research studies.

Entities:  

Mesh:

Year:  2009        PMID: 18985466     DOI: 10.1080/17482960802521126

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  47 in total

1.  [Cryptorchism].

Authors:  S I Volozhin
Journal:  Feldsher Akush       Date:  1975-10

2.  Motor neurone disease: a practical update on diagnosis and management.

Authors:  Clare Wood-Allum; Pamela J Shaw
Journal:  Clin Med (Lond)       Date:  2010-06       Impact factor: 2.659

Review 3.  Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.

Authors:  Paul H Gordon
Journal:  Aging Dis       Date:  2013-10-01       Impact factor: 6.745

Review 4.  Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease.

Authors:  Jeffrey Rosenfeld; Michael J Strong
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

5.  Utility of dissociated intrinsic hand muscle atrophy in the diagnosis of amyotrophic lateral sclerosis.

Authors:  Parvathi Menon; Steve Vucic
Journal:  J Vis Exp       Date:  2014-03-04       Impact factor: 1.355

6.  Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach.

Authors:  Robert Kueffner; Neta Zach; Maya Bronfeld; Raquel Norel; Nazem Atassi; Venkat Balagurusamy; Barbara Di Camillo; Adriano Chio; Merit Cudkowicz; Donna Dillenberger; Javier Garcia-Garcia; Orla Hardiman; Bruce Hoff; Joshua Knight; Melanie L Leitner; Guang Li; Lara Mangravite; Thea Norman; Liuxia Wang; Jinfeng Xiao; Wen-Chieh Fang; Jian Peng; Chen Yang; Huan-Jui Chang; Gustavo Stolovitzky
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

Review 7.  Quo vadis motor neuron disease?

Authors:  Rubika Balendra; Rickie Patani
Journal:  World J Methodol       Date:  2016-03-26

Review 8.  The application of biomarkers in clinical trials for motor neuron disease.

Authors:  Jeban Ganesalingam; Robert Bowser
Journal:  Biomark Med       Date:  2010-04       Impact factor: 2.851

Review 9.  The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.

Authors:  Filippo Baldacci; Sonia Mazzucchi; Alessandra Della Vecchia; Linda Giampietri; Nicola Giannini; Maya Koronyo-Hamaoui; Roberto Ceravolo; Gabriele Siciliano; Ubaldo Bonuccelli; Fanny M Elahi; Andrea Vergallo; Simone Lista; Filippo Sean Giorgi; Harald Hampel
Journal:  Expert Rev Mol Diagn       Date:  2020-02-27       Impact factor: 5.225

Review 10.  [Differential diagnostics of diseases of the brachial plexus].

Authors:  C Ritter; G Wunderlich; S Macht; M Schroeter; G R Fink; H C Lehmann
Journal:  Nervenarzt       Date:  2014-02       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.